A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2–ARE pathway: Therapeutic implications for ALS
Description
Antioxidant defense is crucial in restoring cellular redox homeostasis. Recent findings have suggested that oxidative stress plays pivotal roles in the pathogenesis of many neurodegenerative diseases. Thus, an anti-oxidative stress remedy might be a promising means for the treatment of such disorders. In this study, we employed a novel ligand-based virtual screening system and identified a novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide (CPN-9), which selectively suppressed oxidative stress-induced cell death in a cell-type-independent manner. CPN-9 upregulates NF-E2-related factor 2 (Nrf2), a key transcriptional regulator of the expression of phase II detoxification enzymes and antioxidant proteins, and Nrf2-regulated factors such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunit (GCLM). The CPN-9-mediated upregulation of HO-1, NQO1, and GCLM was abolished by Nrf2 knockdown. Moreover, the antioxidant N-acetylcysteine reduced the protective effect of CPN-9 against oxidative stress-induced cell death with concomitant diminishing of Nrf2 nuclear translocation. These results indicate that CPN-9 exerts its activity via the reactive oxygen species-dependent activation of the Nrf2 signaling pathway in cultured cells. It is noteworthy that the postonset systemic administration of CPN-9 to a transgenic ALS mouse model carrying the H46R mutation in the human Cu/Zn superoxide dismutase (SOD1) gene sustained motor functions and delayed disease progression after onset. Collectively, CPN-9 is a novel Nrf2 activator and a neuroprotective candidate for the treatment of neurodegenerative diseases, including ALS.
Journal
-
- Free Radical Biology and Medicine
-
Free Radical Biology and Medicine 53 (11), 2028-2042, 2012-12
Elsevier BV
- Tweet
Keywords
- Male
- Cell Survival
- NF-E2-Related Factor 2
- Glutamate-Cysteine Ligase
- Drug Evaluation, Preclinical
- Apoptosis
- Mice, Transgenic
- Mice
- Acetamides
- NAD(P)H Dehydrogenase (Quinone)
- Animals
- Humans
- Enzyme Inhibitors
- Amyotrophic Lateral Sclerosis
- Free Radical Scavengers
- Hypoxia-Inducible Factor 1, alpha Subunit
- Antioxidant Response Elements
- Metabolic Detoxication, Phase II
- Acetylcysteine
- Oxidative Stress
- Thiazoles
- Gene Expression Regulation
- Enzyme Induction
- Female
- Lipid Peroxidation
- Apoptosis Regulatory Proteins
- Reactive Oxygen Species
- Heme Oxygenase-1
- HeLa Cells
- Signal Transduction
Details 詳細情報について
-
- CRID
- 1360848657089968128
-
- ISSN
- 08915849
-
- PubMed
- 23000247
-
- Data Source
-
- Crossref
- KAKEN
- OpenAIRE